Advertisement
Case-Based Learning| Volume 33, ISSUE 4, P111-117, April 2023

Download started.

Ok

The pelvic mass: assessment and evaluation

Published:March 10, 2023DOI:https://doi.org/10.1016/j.ogrm.2023.01.009

      Abstract

      A pelvic mass in a common condition and a thorough history and examination is important to identify possible causes. A combination of laboratory investigations and radiological imaging is helpful to reach a diagnosis and also to triage cases of malignancy. In this review we consider common presentations, methods to assess the risk of malignancy and treatment strategies of a range of causes.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Obstetrics, Gynaecology and Reproductive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      Further reading

        • Andreotti R.F.
        • Timmerman D.
        • Strachowski L.M.
        • et al.
        O-RADS US risk stratification and management system: a consensus guideline from the ACR ovarian-adnexal reporting and data system committee.
        Radiology. 2020; 294: 168-185
        • D'Angelo E.
        • Prat J.
        Uterine sarcomas: a review.
        Gynecol Oncol. 2010; 116: 131-139
        • de Haan J.
        • Verheecke M.
        • Amant F.
        Management of ovarian cysts and cancer in pregnancy.
        Facts Views Vis Obgyn. 2015; 7: 25-31
        • Dodge J.E.
        • Covens A.L.
        • Lacchetti C.
        • et al.
        Preoperative identification of a suspicious adnexal mass: a systematic review and meta-analysis.
        Gynecol Oncol. 2012; 126: 157-166
        • Francis M.
        • Dennis N.L.
        • Hirschowitz L.
        • et al.
        Incidence and survival of gynecologic sarcomas in England.
        Int J Gynecol Cancer. 2015; 25: 850-857
        • Greenstein Y.
        • Shah A.J.
        • Vragovic O.
        • et al.
        Tuboovarian abscess. Factors associated with operative intervention after failed antibiotic therapy.
        J Reprod Med. 2013; 58: 101-106
        • Jacobs I.
        • Oram D.
        • Fairbanks J.
        • et al.
        A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer.
        Br J Obstet Gynaecol. 1990; 97: 922-929
        • Jacobs I.J.
        • Menon U.
        • Ryan A.
        • et al.
        Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
        Lancet. 2016; 387: 945-956
        • RCOG
        The management of Ovarian cysts in post menopausal women Green top guideline No 34.
        2016
        • Smith J.
        • Addley H.
        • Freeman S.
        Imaging benign gynaecological conditions.
        Obs Gynae Reprod Med. 2020; 30: 363-370
        • Smith J.
        • Addley H.
        • Freeman S.
        Imaging malignant gynaecological conditions.
        Obs Gynae Reprod Med. 2020; 30: 371-379
        • Vergote I.
        • Tropé C.G.
        • Amant F.
        • et al.
        • European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials Group
        Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
        N Engl J Med. 2010; 363: 943-953